Johns Hopkins Center for Psychedelic and Consciousness Research

Please watch and share our PSA on psychedelic risks and adverse events. It is important to have an evidence-based perspective on the risk/benefit profile of psychedelics: https://lnkd.in/ei_fgm7B?

CPCR Assistant Professor Brandon Weiss and colleagues just published a review examining the clinical utility and relevance of psychedelic therapy for personality disorders (PDs), including safety considerations, gaps and limitations, and recommendations for approaching psychedelic therapy within these more complex clinical populations. Both the DSM-5 categorical model and the newer DSM-AMPD dimensional model are used as frameworks for discussion. https://lnkd.in/evarcDAP

We want to hear your opinions about clinical trial research! What are the reasons you might not be able to join a clinical trial? We are conducting a survey study?to understand concerns and challenges related to clinical trial participation, including factors influencing willingness to join psychedelic trials. Tell us your thoughts at?https://lnkd.in/e2HsFtxV

Huge congratulations to Dr. Andrew Gaddis and colleagues Drs. Frederick Barrett and Albert Garcia-Romeu, PhD on receiving an award to collaborate with certified peer recovery specialists and explore ways to improve how we study the use of psychedelic-assisted therapy to treat substance use disorders.

We are hiring a new postdoc! This postdoctoral fellowship is an excellent opportunity to gain experience (1) managing the operation of clinical drug trials focused on the treatment of PTSD, (2) learning to conduct Psilocybin Therapy, (3) producing new knowledge (data analysis, manuscript writing) about the utility of Psilocybin Therapy for treating PTSD, and (4) becoming skilled in grantsmanship. These training experiences are designed to set up our postdoctoral fellow for an independent career as a clinical scientist.? ? Interested applicants may email their CV and cover letter to Dr. Brandon Weiss (bweiss13@jh.edu).

CPCR faculty Albert Garcia-Romeu, PhD will be presenting TODAY at SXSW at 4:00pm CST. In a joint session, he will present preliminary findings from a pilot study of psilocybin for post-treatment Lyme Disease. If you’re there, check it out! Visit the link for more details: https://lnkd.in/eKmiMRya

CPCR faculty Albert Garcia-Romeu, PhD will present preliminary findings from a pilot study of psilocybin for post-treatment Lyme Disease at SXSW in Austin, TX next week. With colleagues from the University of California San Diego and the Psychedelics and Pain Association, they will host a joint session titled "Beyond the Mind: Psychedelics to Heal the Body." For more info visit: https://lnkd.in/eKmiMRya

Researchers at Johns Hopkins are seeking volunteers for a ~15 minute survey study about psychedelic experiences among veterans. (Note: if you completed a similar survey approximately 8 months ago, please DO NOT fill out the current survey).? ? To participate, please visit: https://lnkd.in/g5sA_iYm?

CPCR postdoc Rebecca Ehrenkranz, PhD, MPH will join a panel discussion focusing on science literacy, public trust in science, and effective methods of communicating research, particularly around controversial or misunderstood topics like psychedelics. They will explore community driven efforts and how the public can participate in and contribute to meaningful scientific research. ? ? This Thursday, March 6th 5-7pm at the MICA Fox Building, Meyerhoff Gallery!

Researchers at Johns Hopkins University are seeking individuals with chronic low back pain and co-occurring depression to participate in a research study looking at the effects of psilocybin, a psychoactive substance found in naturally occurring mushrooms. The study will investigate the psychological effects of psilocybin, including whether or not it can help with chronic low back pain and co-occurring depression. Follow the link to learn more! https://lnkd.in/eiu8VSfs